<s id="wsj_0275.1"> 22
1 	 2 	 (NP[nb]/N)\NP 	 2 	 Georgia-Pacific 's
3 	 2 	 (NP[nb]/N)\NP 	 1 	 bid 's
3 	 4 	 (NP\NP)/NP 	 1 	 bid for
3 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 bid has
3 	 9 	 S[pt]\NP 	 1 	 bid shown <XB>
7 	 4 	 (NP\NP)/NP 	 2 	 Nekoosa for
7 	 5 	 N/N 	 1 	 Nekoosa Great
7 	 6 	 N/N 	 1 	 Nekoosa Northern
8 	 0 	 (S/S)/S[dcl] 	 2 	 has As
9 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 shown has
12 	 11 	 N/N 	 1 	 takeovers uninvited
12 	 13 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 takeovers are
12 	 15 	 S[adj]\NP 	 1 	 takeovers alive <XB>
13 	 0 	 (S/S)/S[dcl] 	 1 	 are As
13 	 14 	 (S\NP)\(S\NP) 	 2 	 are still
13 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 are despite
15 	 13 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 alive are
18 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 reports despite
18 	 17 	 N/N 	 1 	 reports premature
18 	 19 	 (NP\NP)/NP 	 1 	 reports of
21 	 19 	 (NP\NP)/NP 	 2 	 demise of
21 	 20 	 NP[nb]/N 	 1 	 demise their
<\s>
<s id="wsj_0275.2"> 21
3 	 2 	 NP[nb]/N 	 1 	 debate the
3 	 4 	 (NP\NP)/NP 	 1 	 debate about
3 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 debate will
3 	 8 	 (S[b]\NP)/(S[to]\NP) 	 1 	 debate continue <XB>
3 	 10 	 S[b]\NP 	 1 	 debate rage <XB>
6 	 4 	 (NP\NP)/NP 	 2 	 pills about
6 	 5 	 N/N 	 1 	 pills poison
7 	 0 	 S/S 	 1 	 will Therefore
8 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 continue will
9 	 8 	 (S[b]\NP)/(S[to]\NP) 	 2 	 to continue
10 	 9 	 (S[to]\NP)/(S[b]\NP) 	 2 	 rage to
10 	 11 	 ((S\NP)\(S\NP))/NP 	 2 	 rage in
13 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 boardrooms in
13 	 12 	 NP[nb]/N 	 1 	 boardrooms the
13 	 14 	 (NP\NP)/NP 	 1 	 boardrooms of
15 	 14 	 (NP\NP)/NP 	 2 	 corporations of
18 	 11 	 ((S\NP)\(S\NP))/NP 	 3 	 halls in
18 	 17 	 NP[nb]/N 	 1 	 halls the
18 	 19 	 (NP\NP)/NP 	 1 	 halls of
20 	 19 	 (NP\NP)/NP 	 2 	 academia of
<\s>
<s id="wsj_0275.3"> 50
2 	 1 	 N/N 	 1 	 pills poison
2 	 3 	 S[dcl]\NP 	 1 	 pills come
3 	 0 	 (S/S)/S[dcl] 	 2 	 come Although
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 come in
6 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 colors in
6 	 5 	 N/N 	 1 	 colors different
8 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 shapes in
8 	 5 	 N/N 	 1 	 shapes different
10 	 12 	 ((S[dcl]\NP)/NP)/NP 	 1 	 they give
12 	 0 	 (S/S)/S[dcl] 	 1 	 give Although
12 	 11 	 (S\NP)/(S\NP) 	 2 	 give usually
14 	 12 	 ((S[dcl]\NP)/NP)/NP 	 3 	 shareholders give
14 	 13 	 N/N 	 1 	 shareholders current
16 	 12 	 ((S[dcl]\NP)/NP)/NP 	 2 	 right give
16 	 15 	 NP[nb]/N 	 1 	 right the
16 	 18 	 ((S[b]\NP)/PP)/NP 	 1 	 right buy <XB>
18 	 17 	 (S[to]\NP)/(S[b]\NP) 	 2 	 buy to
18 	 35 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 buy if
20 	 18 	 ((S[b]\NP)/PP)/NP 	 3 	 stock buy
20 	 19 	 N/N 	 1 	 stock more
20 	 21 	 (NP\NP)/NP 	 1 	 stock of
23 	 21 	 (NP\NP)/NP 	 2 	 corporation of
23 	 22 	 NP[nb]/N 	 1 	 corporation their
24 	 18 	 ((S[b]\NP)/PP)/NP 	 2 	 at buy
27 	 24 	 PP/NP 	 1 	 discount at
27 	 25 	 NP[nb]/N 	 1 	 discount a
27 	 26 	 N/N 	 1 	 discount large
30 	 29 	 N/N 	 1 	 events certain
30 	 31 	 S[dcl]\NP 	 1 	 events occur
31 	 28 	 (((S\NP)\(S\NP))/((S\NP)\(S\NP)))/S[dcl] 	 4 	 occur if
35 	 28 	 (((S\NP)\(S\NP))/((S\NP)\(S\NP)))/S[dcl] 	 3 	 if if
35 	 33 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 if typically
38 	 36 	 NP[nb]/N 	 1 	 bidder a
38 	 37 	 N/N 	 1 	 bidder hostile
38 	 39 	 (S[dcl]\NP)/NP 	 1 	 bidder acquires
39 	 35 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 acquires if
40 	 39 	 (S[dcl]\NP)/NP 	 2 	 more acquires
40 	 41 	 (NP\NP)/NP 	 1 	 more than
44 	 41 	 (NP\NP)/NP 	 2 	 percentage than
44 	 42 	 NP[nb]/N 	 1 	 percentage a
44 	 43 	 N/N 	 1 	 percentage specified
44 	 45 	 (NP\NP)/NP 	 1 	 percentage of
47 	 46 	 NP[nb]/N 	 1 	 corporation the
47 	 48 	 (NP[nb]/N)\NP 	 2 	 corporation 's
49 	 45 	 (NP\NP)/NP 	 2 	 stock of
49 	 48 	 (NP[nb]/N)\NP 	 1 	 stock 's
<\s>
<s id="wsj_0275.4"> 25
5 	 2 	 NP[nb]/N 	 1 	 rights these
5 	 3 	 N/N 	 1 	 rights discount
5 	 4 	 N/N 	 1 	 rights purchase
5 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 rights may
5 	 9 	 (S[pss]\NP)/PP 	 1 	 rights redeemed <XB>
6 	 0 	 S/S 	 1 	 may However
6 	 7 	 (S\NP)\(S\NP) 	 2 	 may generally
8 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be may
9 	 8 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 redeemed be
9 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 redeemed by
9 	 19 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 redeemed if
10 	 9 	 (S[pss]\NP)/PP 	 2 	 at redeemed
13 	 10 	 PP/NP 	 1 	 cost at
13 	 11 	 NP[nb]/N 	 1 	 cost a
13 	 12 	 N/N 	 1 	 cost nominal
16 	 15 	 NP[nb]/N 	 1 	 corporation the
16 	 17 	 (NP[nb]/N)\NP 	 2 	 corporation 's
18 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 directors by
18 	 17 	 (NP[nb]/N)\NP 	 1 	 directors 's
20 	 21 	 (S[dcl]\NP)/PP 	 1 	 they approve
21 	 19 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 approve if
22 	 21 	 (S[dcl]\NP)/PP 	 2 	 of approve
24 	 22 	 PP/NP 	 1 	 bidder of
24 	 23 	 NP[nb]/N 	 1 	 bidder a
<\s>
<s id="wsj_0275.5"> 34
0 	 1 	 (NP\NP)/NP 	 1 	 Supporters of
0 	 4 	 (S[dcl]\NP)/S[em] 	 1 	 Supporters argue
3 	 1 	 (NP\NP)/NP 	 2 	 pills of
3 	 2 	 N/N 	 1 	 pills poison
5 	 4 	 (S[dcl]\NP)/S[em] 	 2 	 that argue
7 	 6 	 NP[nb]/N 	 1 	 adoption their
7 	 8 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 1 	 adoption forces
8 	 5 	 S[em]/S[dcl] 	 1 	 forces that
9 	 8 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 3 	 bidders forces
9 	 11 	 (S[b]\NP)/PP 	 1 	 bidders negotiate <XB>
10 	 8 	 ((S[dcl]\NP)/(S[to]\NP))/NP 	 2 	 to forces
11 	 10 	 (S[to]\NP)/(S[b]\NP) 	 2 	 negotiate to
12 	 11 	 (S[b]\NP)/PP 	 2 	 with negotiate
14 	 13 	 NP[nb]/N 	 1 	 corporation a
14 	 15 	 (NP[nb]/N)\NP 	 2 	 corporation 's
16 	 12 	 PP/NP 	 1 	 directors with
16 	 15 	 (NP[nb]/N)\NP 	 1 	 directors 's
16 	 18 	 (NP\NP)/(S[dcl]\NP) 	 1 	 directors who
16 	 19 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 directors are <XB>
16 	 21 	 (S[pss]\NP)/PP 	 1 	 directors put <XB>
19 	 18 	 (NP\NP)/(S[dcl]\NP) 	 2 	 are who
19 	 20 	 (S\NP)\(S\NP) 	 2 	 are thereby
21 	 19 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 put are
22 	 21 	 (S[pss]\NP)/PP 	 2 	 in put
25 	 22 	 PP/NP 	 1 	 position in
25 	 23 	 NP[nb]/N 	 1 	 position a
25 	 24 	 N/N 	 1 	 position better
27 	 26 	 (S[to]\NP)/(S[b]\NP) 	 2 	 pursue to
30 	 27 	 (S[b]\NP)/NP 	 2 	 interests pursue
30 	 28 	 NP[nb]/N 	 1 	 interests the
30 	 29 	 N/N 	 1 	 interests long-term
30 	 31 	 (NP\NP)/NP 	 1 	 interests of
33 	 31 	 (NP\NP)/NP 	 2 	 corporation of
33 	 32 	 NP[nb]/N 	 1 	 corporation the
<\s>
<s id="wsj_0275.6"> 27
1 	 0 	 N/N 	 1 	 studies Recent
1 	 2 	 (NP\NP)/NP 	 1 	 studies by
1 	 6 	 (S[dcl]\NP)/S[em] 	 1 	 studies conclude
5 	 2 	 (NP\NP)/NP 	 2 	 Co. by
5 	 3 	 N/N 	 1 	 Co. Georgeson
5 	 4 	 N/N 	 1 	 Co. &
7 	 6 	 (S[dcl]\NP)/S[em] 	 2 	 that conclude
8 	 9 	 (NP\NP)/NP 	 1 	 corporations with
8 	 12 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 corporations have
8 	 13 	 (S[pt]\NP)/NP 	 1 	 corporations experienced <XB>
11 	 9 	 (NP\NP)/NP 	 2 	 pills with
11 	 10 	 N/N 	 1 	 pills poison
12 	 7 	 S[em]/S[dcl] 	 1 	 have that
13 	 12 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 experienced have
13 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 experienced during
16 	 13 	 (S[pt]\NP)/NP 	 2 	 appreciation experienced
16 	 14 	 N/N 	 1 	 appreciation greater
16 	 15 	 N/N 	 1 	 appreciation stock-price
16 	 17 	 (NP\NP)/NP 	 1 	 appreciation than
18 	 17 	 (NP\NP)/NP 	 2 	 corporations than
18 	 19 	 (NP\NP)/NP 	 1 	 corporations without
21 	 19 	 (NP\NP)/NP 	 2 	 pills without
21 	 20 	 N/N 	 1 	 pills poison
26 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 years during
26 	 23 	 NP[nb]/N 	 1 	 years the
26 	 24 	 N/N 	 1 	 years past
26 	 25 	 N/N 	 1 	 years few
<\s>
<s id="wsj_0275.7"> 30
0 	 1 	 (NP\NP)/NP 	 1 	 Critics of
0 	 4 	 (S[dcl]\NP)/S[em] 	 1 	 Critics argue
3 	 1 	 (NP\NP)/NP 	 2 	 pills of
3 	 2 	 N/N 	 1 	 pills poison
5 	 4 	 (S[dcl]\NP)/S[em] 	 2 	 that argue
6 	 7 	 (S[dcl]\NP)/NP 	 1 	 they harm
6 	 10 	 ((S[ng]\NP)/(S[b]\NP))/NP 	 1 	 they letting <XB>
6 	 21 	 ((S[ng]\NP)/PP)/NP 	 1 	 they deterring <XB>
7 	 5 	 S[em]/S[dcl] 	 1 	 harm that
7 	 9 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 harm by
7 	 20 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 harm by <XU>
8 	 7 	 (S[dcl]\NP)/NP 	 2 	 shareholders harm
10 	 9 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 letting by
12 	 10 	 ((S[ng]\NP)/(S[b]\NP))/NP 	 3 	 management letting
12 	 11 	 N/N 	 1 	 management corporate
12 	 13 	 (S[b]\NP)/NP 	 1 	 management defeat <XB>
13 	 10 	 ((S[ng]\NP)/(S[b]\NP))/NP 	 2 	 defeat letting
15 	 13 	 (S[b]\NP)/NP 	 2 	 bids defeat
15 	 14 	 N/N 	 1 	 bids takeover
15 	 16 	 (NP\NP)/NP 	 1 	 bids at
18 	 16 	 (NP\NP)/NP 	 2 	 prices at
18 	 17 	 N/N 	 1 	 prices premium
21 	 20 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 deterring by
23 	 21 	 ((S[ng]\NP)/PP)/NP 	 3 	 bids deterring
23 	 22 	 N/N 	 1 	 bids premium
24 	 21 	 ((S[ng]\NP)/PP)/NP 	 2 	 from deterring
26 	 24 	 PP/(S[ng]\NP) 	 1 	 being from
26 	 25 	 (S\NP)/(S\NP) 	 2 	 being ever
27 	 26 	 (S[ng]\NP)/(S[pss]\NP) 	 2 	 made being
28 	 27 	 (S[pss]\NP)/PP 	 2 	 to made
29 	 28 	 PP/NP 	 1 	 shareholders to
<\s>
<s id="wsj_0275.8"> 30
1 	 0 	 NP[nb]/N 	 1 	 critics These
1 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 critics are
1 	 3 	 S[pss]\NP 	 1 	 critics backed <XB>
3 	 2 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 backed are
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 backed by
7 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 studies by
7 	 5 	 N/N 	 1 	 studies several
7 	 6 	 N/N 	 1 	 studies academic
7 	 8 	 (S[ng]\NP)/S[em] 	 1 	 studies showing <XB>
9 	 8 	 (S[ng]\NP)/S[em] 	 2 	 that showing
11 	 10 	 NP[nb]/N 	 1 	 adoption the
11 	 12 	 (NP\NP)/NP 	 1 	 adoption of
11 	 15 	 (S[dcl]\NP)/NP 	 1 	 adoption reduces
14 	 12 	 (NP\NP)/NP 	 2 	 pills of
14 	 13 	 N/N 	 1 	 pills poison
15 	 9 	 S[em]/S[dcl] 	 1 	 reduces that
15 	 20 	 ((S\NP)\(S\NP))/NP 	 2 	 reduces in
15 	 27 	 ((S\NP)\(S\NP))/NP 	 2 	 reduces over <XU>
17 	 15 	 (S[dcl]\NP)/NP 	 2 	 values reduces
17 	 16 	 N/N 	 1 	 values shareholder
19 	 18 	 (((S\NP)\(S\NP))/((S\NP)\(S\NP)))/(((S\NP)\(S\NP))/((S\NP)\(S\NP))) 	 4 	 merely not
20 	 19 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 in merely
23 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 run in
23 	 21 	 NP[nb]/N 	 1 	 run the
23 	 22 	 N/N 	 1 	 run short
25 	 26 	 conj\conj 	 1 	 but also
27 	 19 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 over merely
29 	 27 	 ((S\NP)\(S\NP))/NP 	 3 	 periods over
29 	 28 	 N/N 	 1 	 periods longer
<\s>
<s id="wsj_0275.9"> 31
1 	 0 	 N/N 	 1 	 investors Institutional
1 	 2 	 (NP\NP)/(S[dcl]\NP) 	 1 	 investors that
1 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 investors must <XB>
1 	 4 	 (S[b]\NP)/NP 	 1 	 investors evaluate <XB>
1 	 11 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 investors are
1 	 12 	 (S[pss]\NP)/PP 	 1 	 investors interested <XB>
3 	 2 	 (NP\NP)/(S[dcl]\NP) 	 2 	 must that
4 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 evaluate must
4 	 7 	 ((S\NP)\(S\NP))/NP 	 2 	 evaluate on
6 	 4 	 (S[b]\NP)/NP 	 2 	 pills evaluate
6 	 5 	 N/N 	 1 	 pills poison
10 	 7 	 ((S\NP)\(S\NP))/NP 	 3 	 basis on
10 	 8 	 NP[nb]/N 	 1 	 basis a
10 	 9 	 N/N 	 1 	 basis regular
12 	 11 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 interested are
12 	 13 	 (S\NP)\(S\NP) 	 2 	 interested less
12 	 18 	 ((S\NP)\(S\NP))/PP 	 2 	 interested than
14 	 12 	 (S[pss]\NP)/PP 	 2 	 in interested
17 	 14 	 PP/NP 	 1 	 debate in
17 	 15 	 NP[nb]/N 	 1 	 debate this
17 	 16 	 N/N 	 1 	 debate general
19 	 18 	 ((S\NP)\(S\NP))/PP 	 3 	 in than
21 	 19 	 PP/NP 	 1 	 answers in
21 	 20 	 NP[nb]/N 	 1 	 answers the
21 	 22 	 (NP\NP)/NP 	 1 	 answers to
24 	 22 	 (NP\NP)/NP 	 2 	 questions to
24 	 23 	 N/N 	 1 	 questions specific
24 	 25 	 (NP\NP)/NP 	 1 	 questions about
27 	 25 	 (NP\NP)/NP 	 2 	 corporation about
27 	 26 	 NP[nb]/N 	 1 	 corporation the
27 	 28 	 (S[ng]\NP)/NP 	 1 	 corporation issuing <XB>
30 	 28 	 (S[ng]\NP)/NP 	 2 	 pill issuing
30 	 29 	 NP[nb]/N 	 1 	 pill the
<\s>
<s id="wsj_0275.10"> 13
2 	 0 	 (S[q]/(S[b]\NP))/NP 	 2 	 corporation Does
2 	 1 	 NP[nb]/N 	 1 	 corporation this
2 	 3 	 (S[b]\NP)/NP 	 1 	 corporation have <XB>
3 	 0 	 (S[q]/(S[b]\NP))/NP 	 1 	 have Does
7 	 3 	 (S[b]\NP)/NP 	 2 	 team have
7 	 4 	 NP[nb]/N 	 1 	 team a
7 	 5 	 N/N 	 1 	 team high-quality
7 	 6 	 N/N 	 1 	 team management
7 	 8 	 (NP\NP)/NP 	 1 	 team with
12 	 8 	 (NP\NP)/NP 	 2 	 record with
12 	 9 	 NP[nb]/N 	 1 	 record a
12 	 10 	 N/N 	 1 	 record good
12 	 11 	 N/N 	 1 	 record track
<\s>
<s id="wsj_0275.11"> 22
2 	 0 	 (S[q]/(S[b]\NP))/NP 	 2 	 team Does
2 	 1 	 NP[nb]/N 	 1 	 team this
2 	 3 	 (S[b]\NP)/NP 	 1 	 team have <XB>
3 	 0 	 (S[q]/(S[b]\NP))/NP 	 1 	 have Does
6 	 3 	 (S[b]\NP)/NP 	 2 	 strategy have
6 	 4 	 NP[nb]/N 	 1 	 strategy a
6 	 5 	 N/N 	 1 	 strategy viable
6 	 7 	 (NP\NP)/(S[ng]\NP) 	 1 	 strategy for
8 	 7 	 (NP\NP)/(S[ng]\NP) 	 2 	 improving for
10 	 8 	 (S[ng]\NP)/NP 	 2 	 values improving
10 	 9 	 N/N 	 1 	 values shareholder
15 	 13 	 (S[q]/(S[b]\NP))/NP 	 2 	 strategy does
15 	 14 	 NP[nb]/N 	 1 	 strategy this
15 	 16 	 (S[b]\NP)/NP 	 1 	 strategy require <XB>
16 	 13 	 (S[q]/(S[b]\NP))/NP 	 1 	 require does
16 	 18 	 ((S\NP)\(S\NP))/NP 	 2 	 require over
17 	 16 	 (S[b]\NP)/NP 	 2 	 implementation require
21 	 18 	 ((S\NP)\(S\NP))/NP 	 3 	 period over
21 	 19 	 NP[nb]/N 	 1 	 period an
21 	 20 	 N/N 	 1 	 period extended
<\s>
<s id="wsj_0275.12"> 22
2 	 0 	 (S[q]/(S[b]\NP))/NP 	 2 	 adoption Will
2 	 1 	 NP[nb]/N 	 1 	 adoption the
2 	 3 	 (NP\NP)/NP 	 1 	 adoption of
2 	 12 	 (S[b]\NP)/NP 	 1 	 adoption improve <XB>
6 	 3 	 (NP\NP)/NP 	 2 	 form of
6 	 4 	 NP[nb]/N 	 1 	 form this
6 	 5 	 N/N 	 1 	 form particular
6 	 7 	 (NP\NP)/NP 	 1 	 form of
10 	 7 	 (NP\NP)/NP 	 2 	 pill of
10 	 8 	 NP[nb]/N 	 1 	 pill a
10 	 9 	 N/N 	 1 	 pill poison
12 	 0 	 (S[q]/(S[b]\NP))/NP 	 1 	 improve Will
12 	 11 	 (S\NP)/(S\NP) 	 2 	 improve significantly
14 	 12 	 (S[b]\NP)/NP 	 2 	 chances improve
14 	 13 	 NP[nb]/N 	 1 	 chances the
15 	 14 	 N/S[for] 	 1 	 for chances
16 	 15 	 (S[for]/(S[to]\NP))/NP 	 2 	 management for
16 	 18 	 (S[b]\NP)/NP 	 1 	 management carry <XB>
17 	 15 	 (S[for]/(S[to]\NP))/NP 	 1 	 to for
18 	 17 	 (S[to]\NP)/(S[b]\NP) 	 2 	 carry to
18 	 19 	 (S\NP)\(S\NP) 	 2 	 carry out
21 	 18 	 (S[b]\NP)/NP 	 2 	 strategy carry
21 	 20 	 NP[nb]/N 	 1 	 strategy this
<\s>
<s id="wsj_0275.13"> 23
2 	 1 	 NP[nb]/N 	 1 	 answers the
2 	 3 	 (NP\NP)/NP 	 1 	 answers to
2 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 answers are
2 	 7 	 S[adj]\NP 	 1 	 answers affirmative <XB>
5 	 3 	 (NP\NP)/NP 	 2 	 questions to
5 	 4 	 NP[nb]/N 	 1 	 questions these
6 	 0 	 (S/S)/S[dcl] 	 2 	 are If
7 	 6 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 affirmative are
11 	 10 	 N/N 	 1 	 investors institutional
11 	 12 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 investors are
11 	 13 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 investors likely <XB>
12 	 0 	 (S/S)/S[dcl] 	 1 	 are If
12 	 9 	 S/S 	 1 	 are then
13 	 12 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 likely are
14 	 13 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to likely
15 	 14 	 (S[to]\NP)/(S[b]\NP) 	 2 	 be to
17 	 15 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 disposed be
17 	 16 	 (S[adj]\NP)/(S[adj]\NP) 	 2 	 disposed favorably
18 	 17 	 (S[adj]\NP)/PP 	 2 	 toward disposed
22 	 18 	 PP/NP 	 1 	 pill toward
22 	 19 	 NP[nb]/N 	 1 	 pill a
22 	 20 	 N/N 	 1 	 pill specific
22 	 21 	 N/N 	 1 	 pill poison
<\s>
<s id="wsj_0275.14"> 16
3 	 2 	 NP[nb]/N 	 1 	 problem the
3 	 4 	 (S[dcl]\NP)/S[em] 	 1 	 problem is
4 	 0 	 S/S 	 1 	 is However
5 	 4 	 (S[dcl]\NP)/S[em] 	 2 	 that is
9 	 7 	 N/N 	 1 	 pills most
9 	 8 	 N/N 	 1 	 pills poison
9 	 10 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 pills are
9 	 11 	 S[pss]\NP 	 1 	 pills adopted <XB>
10 	 6 	 (S/S)/S[dcl] 	 2 	 are once
11 	 10 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 adopted are
13 	 14 	 S[dcl]\NP 	 1 	 they survive
14 	 5 	 S[em]/S[dcl] 	 1 	 survive that
14 	 6 	 (S/S)/S[dcl] 	 1 	 survive once
14 	 15 	 (S\NP)\(S\NP) 	 2 	 survive forever
<\s>
<s id="wsj_0275.15"> 17
4 	 1 	 NP[nb]/N 	 1 	 team the
4 	 2 	 N/N 	 1 	 team current
4 	 3 	 N/N 	 1 	 team management
4 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 team may
4 	 7 	 S[adj]\NP 	 1 	 team outstanding <XB>
5 	 0 	 (S/S)/S[dcl] 	 2 	 may Although
6 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be may
7 	 6 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 outstanding be
9 	 0 	 (S/S)/S[dcl] 	 1 	 who Although
10 	 9 	 S[wq]/(S[dcl]\NP) 	 1 	 will who
11 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
11 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 be in
13 	 11 	 (S[b]\NP)/NP 	 2 	 CEO be
13 	 12 	 NP[nb]/N 	 1 	 CEO the
16 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 years in
16 	 15 	 N/N 	 1 	 years 10
<\s>
<s id="wsj_0275.16"> 16
3 	 1 	 NP[nb]/N 	 1 	 strategy the
3 	 2 	 N/N 	 1 	 strategy five-year
3 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 strategy may
3 	 6 	 S[adj]\NP 	 1 	 strategy excellent <XB>
4 	 0 	 (S/S)/S[dcl] 	 2 	 may Although
5 	 4 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be may
6 	 5 	 (S[b]\NP)/(S[adj]\NP) 	 2 	 excellent be
8 	 0 	 (S/S)/S[dcl] 	 1 	 what Although
9 	 8 	 S[wq]/(S[dcl]\NP) 	 1 	 will what
10 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
10 	 13 	 ((S\NP)\(S\NP))/NP 	 2 	 be in
12 	 10 	 (S[b]\NP)/NP 	 2 	 strategy be
12 	 11 	 NP[nb]/N 	 1 	 strategy the
15 	 13 	 ((S\NP)\(S\NP))/NP 	 3 	 years in
15 	 14 	 N/N 	 1 	 years 25
<\s>
<s id="wsj_0275.17"> 10
1 	 0 	 NP[nb]/N 	 1 	 solution The
1 	 2 	 (NP\NP)/NP 	 1 	 solution to
1 	 5 	 (S[dcl]\NP)/NP 	 1 	 solution is
4 	 2 	 (NP\NP)/NP 	 2 	 problem to
4 	 3 	 NP[nb]/N 	 1 	 problem this
9 	 5 	 (S[dcl]\NP)/NP 	 2 	 pill is
9 	 6 	 NP[nb]/N 	 1 	 pill a
9 	 7 	 N/N 	 1 	 pill time-limited
9 	 8 	 N/N 	 1 	 pill poison
<\s>
<s id="wsj_0275.18"> 26
1 	 0 	 NP[nb]/N 	 1 	 limit The
1 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 limit could
1 	 3 	 (S[b]\NP)/PP 	 1 	 limit range <XB>
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 range could
3 	 11 	 ((S\NP)\(S\NP))/PP 	 2 	 range depending
6 	 4 	 (PP/PP)/NP 	 2 	 years from
6 	 5 	 N/N 	 1 	 years three
7 	 3 	 (S[b]\NP)/PP 	 2 	 to range
7 	 4 	 (PP/PP)/NP 	 1 	 to from
9 	 7 	 PP/NP 	 1 	 years to
9 	 8 	 N/N 	 1 	 years seven
12 	 11 	 ((S\NP)\(S\NP))/PP 	 3 	 on depending
14 	 12 	 PP/NP 	 1 	 composition on
14 	 13 	 NP[nb]/N 	 1 	 composition the
14 	 15 	 (NP\NP)/NP 	 1 	 composition of
18 	 15 	 (NP\NP)/NP 	 2 	 team of
18 	 16 	 NP[nb]/N 	 1 	 team the
18 	 17 	 N/N 	 1 	 team management
21 	 12 	 PP/NP 	 1 	 nature on
21 	 20 	 NP[nb]/N 	 1 	 nature the
21 	 22 	 (NP\NP)/NP 	 1 	 nature of
25 	 22 	 (NP\NP)/NP 	 2 	 plan of
25 	 23 	 NP[nb]/N 	 1 	 plan its
25 	 24 	 N/N 	 1 	 plan strategic
<\s>
<s id="wsj_0275.19"> 44
2 	 0 	 (S/S)/NP 	 2 	 end At
2 	 1 	 NP[nb]/N 	 1 	 end the
2 	 3 	 (NP\NP)/NP 	 1 	 end of
5 	 3 	 (NP\NP)/NP 	 2 	 period of
5 	 4 	 NP[nb]/N 	 1 	 period this
9 	 7 	 NP[nb]/N 	 1 	 pill the
9 	 8 	 N/N 	 1 	 pill poison
9 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 pill would
9 	 12 	 S[pss]\NP 	 1 	 pill eliminated <XB>
10 	 0 	 (S/S)/NP 	 1 	 would At
11 	 10 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be would
12 	 11 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 eliminated be
12 	 13 	 (S\NP)\(S\NP) 	 2 	 eliminated automatically
12 	 15 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 eliminated unless
19 	 16 	 NP[nb]/N 	 1 	 pill a
19 	 17 	 N/N 	 1 	 pill new
19 	 18 	 N/N 	 1 	 pill poison
19 	 20 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 pill were
19 	 21 	 S[pss]\NP 	 1 	 pill approved <XB>
20 	 15 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 were unless
21 	 20 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 approved were
21 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 approved by
25 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 shareholders by
25 	 23 	 NP[nb]/N 	 1 	 shareholders the
25 	 24 	 N/N 	 1 	 shareholders then-current
25 	 27 	 (NP\NP)/(S[dcl]\NP) 	 1 	 shareholders who
25 	 28 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 shareholders would <XB>
25 	 29 	 (S[b]\NP)/NP 	 1 	 shareholders have <XB>
28 	 27 	 (NP\NP)/(S[dcl]\NP) 	 2 	 would who
29 	 28 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 have would
29 	 41 	 ((S\NP)\(S\NP))/NP 	 2 	 have at
31 	 29 	 (S[b]\NP)/NP 	 2 	 opportunity have
31 	 30 	 NP[nb]/N 	 1 	 opportunity an
31 	 33 	 (S[b]\NP)/NP 	 1 	 opportunity evaluate <XB>
33 	 32 	 (S[to]\NP)/(S[b]\NP) 	 2 	 evaluate to
35 	 34 	 NP[nb]/N 	 1 	 corporation the
35 	 36 	 (NP[nb]/N)\NP 	 2 	 corporation 's
37 	 33 	 (S[b]\NP)/NP 	 2 	 strategy evaluate
37 	 36 	 (NP[nb]/N)\NP 	 1 	 strategy 's
40 	 33 	 (S[b]\NP)/NP 	 2 	 team evaluate
40 	 36 	 (NP[nb]/N)\NP 	 1 	 team 's
40 	 39 	 N/N 	 1 	 team management
43 	 41 	 ((S\NP)\(S\NP))/NP 	 3 	 time at
43 	 42 	 NP[nb]/N 	 1 	 time that
<\s>
<s id="wsj_0275.20"> 27
2 	 0 	 N/N 	 1 	 example One
2 	 1 	 N/N 	 1 	 example rare
2 	 3 	 (NP\NP)/NP 	 1 	 example of
2 	 8 	 (S[dcl]\NP)/NP 	 1 	 example is
7 	 3 	 (NP\NP)/NP 	 2 	 pill of
7 	 4 	 NP[nb]/N 	 1 	 pill a
7 	 5 	 N/N 	 1 	 pill time-limited
7 	 6 	 N/N 	 1 	 pill poison
12 	 8 	 (S[dcl]\NP)/NP 	 2 	 plan is
12 	 9 	 NP[nb]/N 	 1 	 plan the
12 	 10 	 N/N 	 1 	 plan shareholder
12 	 11 	 N/N 	 1 	 plan rights
12 	 13 	 S[pss]\NP 	 1 	 plan adopted <XB>
13 	 14 	 ((S\NP)\(S\NP))/NP 	 2 	 adopted by
13 	 17 	 (S\NP)\(S\NP) 	 2 	 adopted year
13 	 18 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 adopted after
15 	 14 	 ((S\NP)\(S\NP))/NP 	 3 	 Pennzoil by
17 	 16 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 year last
19 	 20 	 ((S[dcl]\NP)/PP)/NP 	 1 	 it received
20 	 18 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 received after
24 	 20 	 ((S[dcl]\NP)/PP)/NP 	 3 	 settlement received
24 	 21 	 NP[nb]/N 	 1 	 settlement a
24 	 22 	 N/N 	 1 	 settlement huge
24 	 23 	 N/N 	 1 	 settlement litigation
25 	 20 	 ((S[dcl]\NP)/PP)/NP 	 2 	 from received
26 	 25 	 PP/NP 	 1 	 Texaco from
<\s>
<s id="wsj_0275.21"> 25
0 	 1 	 (NP[nb]/N)\NP 	 2 	 Pennzoil 's
3 	 1 	 (NP[nb]/N)\NP 	 1 	 pill 's
3 	 2 	 N/N 	 1 	 pill poison
3 	 4 	 (S[dcl]\NP)/NP 	 1 	 pill covers
4 	 7 	 (((S\NP)\(S\NP))/(S[to]\NP))/N 	 2 	 covers in
6 	 4 	 (S[dcl]\NP)/NP 	 2 	 years covers
6 	 5 	 N/N 	 1 	 years five
8 	 7 	 (((S\NP)\(S\NP))/(S[to]\NP))/N 	 4 	 order in
9 	 7 	 (((S\NP)\(S\NP))/(S[to]\NP))/N 	 3 	 to in
10 	 9 	 (S[to]\NP)/(S[b]\NP) 	 2 	 give to
12 	 10 	 ((S[b]\NP)/NP)/NP 	 3 	 management give
12 	 11 	 N/N 	 1 	 management current
14 	 10 	 ((S[b]\NP)/NP)/NP 	 2 	 time give
14 	 13 	 N/N 	 1 	 time enough
16 	 15 	 (S[to]\NP)/(S[b]\NP) 	 2 	 put to
16 	 21 	 ((S\NP)\(S\NP))/NP 	 2 	 put in
18 	 16 	 ((S[b]\NP)/PP)/NP 	 3 	 proceeds put
18 	 17 	 NP[nb]/N 	 1 	 proceeds these
19 	 16 	 ((S[b]\NP)/PP)/NP 	 2 	 to put
20 	 19 	 PP/NP 	 1 	 work to
24 	 21 	 ((S\NP)\(S\NP))/NP 	 3 	 manner in
24 	 22 	 NP[nb]/N 	 1 	 manner a
24 	 23 	 N/N 	 1 	 manner prudent
<\s>
<s id="wsj_0275.22"> 19
2 	 0 	 NP[nb]/N 	 1 	 example Another
2 	 1 	 N/N 	 1 	 example interesting
2 	 3 	 (S[dcl]\NP)/NP 	 1 	 example is
6 	 3 	 (S[dcl]\NP)/NP 	 2 	 pill is
6 	 4 	 NP[nb]/N 	 1 	 pill the
6 	 5 	 N/N 	 1 	 pill poison
6 	 7 	 S[pss]\NP 	 1 	 pill adopted <XB>
7 	 8 	 (S\NP)\(S\NP) 	 2 	 adopted recently
7 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 adopted by
13 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 Inc. by
13 	 10 	 N/N 	 1 	 Inc. Pittsburgh-based
13 	 11 	 N/N 	 1 	 Inc. National
13 	 12 	 N/N 	 1 	 Inc. Intergroup
18 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 company by
18 	 15 	 NP[nb]/N 	 1 	 company a
18 	 16 	 N/N 	 1 	 company diversified
18 	 17 	 N/N 	 1 	 company holding
<\s>
<s id="wsj_0275.23"> 28
1 	 2 	 ((N/N)\(N/N))/NP 	 2 	 State of
3 	 2 	 ((N/N)\(N/N))/NP 	 3 	 Wisconsin of
5 	 0 	 NP[nb]/N 	 1 	 Board The
5 	 1 	 N/N 	 1 	 Board State
5 	 4 	 N/N 	 1 	 Board Investment
5 	 7 	 (NP\NP)/(S[dcl]\NP) 	 1 	 Board which
5 	 8 	 (S[dcl]\NP)/NP 	 1 	 Board owned <XB>
5 	 19 	 (S[dcl]\NP)/(S[to]\NP) 	 1 	 Board worked
5 	 23 	 (S[b]\NP)/NP 	 1 	 Board devise <XB>
8 	 7 	 (NP\NP)/(S[dcl]\NP) 	 2 	 owned which
10 	 9 	 (N/N)/(N/N) 	 2 	 7 about
11 	 8 	 (S[dcl]\NP)/NP 	 2 	 % owned
11 	 10 	 N/N 	 1 	 % 7
11 	 12 	 (NP\NP)/NP 	 1 	 % of
14 	 13 	 NP[nb]/N 	 1 	 company the
14 	 15 	 (NP[nb]/N)\NP 	 2 	 company 's
17 	 12 	 (NP\NP)/NP 	 2 	 stock of
17 	 15 	 (NP[nb]/N)\NP 	 1 	 stock 's
17 	 16 	 N/N 	 1 	 stock voting
19 	 20 	 ((S\NP)\(S\NP))/NP 	 2 	 worked with
21 	 20 	 ((S\NP)\(S\NP))/NP 	 3 	 management with
22 	 19 	 (S[dcl]\NP)/(S[to]\NP) 	 2 	 to worked
23 	 22 	 (S[to]\NP)/(S[b]\NP) 	 2 	 devise to
27 	 23 	 (S[b]\NP)/NP 	 2 	 pill devise
27 	 24 	 NP[nb]/N 	 1 	 pill a
27 	 25 	 N/N 	 1 	 pill time-limited
27 	 26 	 N/N 	 1 	 pill poison
<\s>
<s id="wsj_0275.24"> 15
1 	 0 	 NP[nb]/N 	 1 	 pill This
1 	 3 	 S[dcl]\NP 	 1 	 pill expires
1 	 8 	 S[pss]\NP 	 1 	 pill continued <XB>
3 	 2 	 (S\NP)/(S\NP) 	 2 	 expires automatically
3 	 4 	 ((S\NP)\(S\NP))/NP 	 2 	 expires after
3 	 7 	 ((S\NP)\(S\NP))/(S[pss]\NP) 	 2 	 expires unless
6 	 4 	 ((S\NP)\(S\NP))/NP 	 3 	 years after
6 	 5 	 N/N 	 1 	 years three
8 	 7 	 ((S\NP)\(S\NP))/(S[pss]\NP) 	 3 	 continued unless
8 	 9 	 ((S\NP)\(S\NP))/NP 	 2 	 continued by
11 	 9 	 ((S\NP)\(S\NP))/NP 	 3 	 vote by
11 	 10 	 NP[nb]/N 	 1 	 vote a
11 	 12 	 (NP\NP)/NP 	 1 	 vote of
14 	 12 	 (NP\NP)/NP 	 2 	 shareholders of
14 	 13 	 NP[nb]/N 	 1 	 shareholders the
<\s>
<s id="wsj_0275.25"> 48
1 	 0 	 NP[nb]/N 	 1 	 attitude The
1 	 2 	 (NP\NP)/NP 	 1 	 attitude of
1 	 7 	 (S[dcl]\NP)/NP 	 1 	 attitude reflects
1 	 23 	 S[pss]\NP 	 1 	 attitude shown <XB>
6 	 2 	 (NP\NP)/NP 	 2 	 Board of
6 	 3 	 NP[nb]/N 	 1 	 Board the
6 	 4 	 N/N 	 1 	 Board Wisconsin
6 	 5 	 N/N 	 1 	 Board Investment
7 	 22 	 ((S\NP)\(S\NP))/(S[pss]\NP) 	 2 	 reflects as
10 	 7 	 (S[dcl]\NP)/NP 	 2 	 receptivity reflects
10 	 8 	 NP[nb]/N 	 1 	 receptivity a
10 	 9 	 N/N 	 1 	 receptivity growing
10 	 11 	 (NP\NP)/NP 	 1 	 receptivity to
10 	 15 	 (NP\NP)/NP 	 1 	 receptivity on
14 	 11 	 (NP\NP)/NP 	 2 	 pills to
14 	 12 	 N/N 	 1 	 pills time-limited
14 	 13 	 N/N 	 1 	 pills poison
17 	 15 	 (NP\NP)/NP 	 2 	 part on
17 	 16 	 NP[nb]/N 	 1 	 part the
17 	 18 	 (NP\NP)/NP 	 1 	 part of
20 	 18 	 (NP\NP)/NP 	 2 	 investors of
20 	 19 	 N/N 	 1 	 investors institutional
23 	 22 	 ((S\NP)\(S\NP))/(S[pss]\NP) 	 3 	 shown as
23 	 24 	 ((S\NP)\(S\NP))/NP 	 2 	 shown by
26 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 discussions by
26 	 25 	 NP[nb]/N 	 1 	 discussions the
26 	 27 	 (NP\NP)/NP 	 1 	 discussions at
29 	 27 	 (NP\NP)/NP 	 2 	 meetings at
29 	 28 	 N/N 	 1 	 meetings recent
29 	 30 	 (NP\NP)/NP 	 1 	 meetings of
32 	 30 	 (NP\NP)/NP 	 2 	 Council of
32 	 31 	 NP[nb]/N 	 1 	 Council the
32 	 33 	 (NP\NP)/NP 	 1 	 Council of
35 	 33 	 (NP\NP)/NP 	 2 	 Investors of
35 	 34 	 N/N 	 1 	 Investors Institutional
39 	 24 	 ((S\NP)\(S\NP))/NP 	 3 	 survey by
39 	 37 	 NP[nb]/N 	 1 	 survey my
39 	 38 	 N/N 	 1 	 survey informal
39 	 40 	 (NP\NP)/NP 	 1 	 survey of
43 	 40 	 (NP\NP)/NP 	 2 	 plans of
43 	 41 	 N/N 	 1 	 plans several
43 	 42 	 N/N 	 1 	 plans retirement
43 	 44 	 (NP\NP)/NP 	 1 	 plans with
47 	 44 	 (NP\NP)/NP 	 2 	 positions with
47 	 45 	 N/N 	 1 	 positions large
47 	 46 	 N/N 	 1 	 positions stock
<\s>
<s id="wsj_0275.26"> 26
1 	 0 	 (N/N)/(N/N) 	 2 	 widespread More
3 	 1 	 N/N 	 1 	 limits widespread
3 	 2 	 N/N 	 1 	 limits time
3 	 4 	 (NP\NP)/NP 	 1 	 limits on
3 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 limits would
3 	 8 	 ((S[b]\NP)/(S[to]\NP))/NP 	 1 	 limits allow <XB>
6 	 4 	 (NP\NP)/NP 	 2 	 pills on
6 	 5 	 N/N 	 1 	 pills poison
8 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 allow would
9 	 8 	 ((S[b]\NP)/(S[to]\NP))/NP 	 3 	 shareholders allow
9 	 11 	 (S[b]\NP)/NP 	 1 	 shareholders evaluate <XB>
10 	 8 	 ((S[b]\NP)/(S[to]\NP))/NP 	 2 	 to allow
11 	 10 	 (S[to]\NP)/(S[b]\NP) 	 2 	 evaluate to
11 	 16 	 ((S\NP)\(S\NP))/NP 	 2 	 evaluate within
15 	 11 	 (S[b]\NP)/NP 	 2 	 pill evaluate
15 	 12 	 NP[nb]/N 	 1 	 pill a
15 	 13 	 N/N 	 1 	 pill specific
15 	 14 	 N/N 	 1 	 pill poison
18 	 16 	 ((S\NP)\(S\NP))/NP 	 3 	 context within
18 	 17 	 NP[nb]/N 	 1 	 context the
18 	 19 	 (NP\NP)/NP 	 1 	 context of
23 	 20 	 NP[nb]/N 	 1 	 team a
23 	 21 	 N/N 	 1 	 team specific
23 	 22 	 N/N 	 1 	 team management
23 	 24 	 (NP[nb]/N)\NP 	 2 	 team 's
25 	 19 	 (NP\NP)/NP 	 2 	 strategy of
25 	 24 	 (NP[nb]/N)\NP 	 1 	 strategy 's
<\s>
<s id="wsj_0275.27"> 22
2 	 0 	 NP/NP 	 1 	 analysis Such
2 	 1 	 N/N 	 1 	 analysis concrete
2 	 3 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 analysis is
2 	 4 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 analysis likely <XB>
4 	 3 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 likely is
5 	 4 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to likely
6 	 5 	 (S[to]\NP)/(S[b]\NP) 	 2 	 lead to
6 	 7 	 ((S\NP)\(S\NP))/NP 	 2 	 lead to
9 	 8 	 (N/N)/(N/N) 	 2 	 fruitful more
10 	 7 	 ((S\NP)\(S\NP))/NP 	 3 	 dialogue to
10 	 9 	 N/N 	 1 	 dialogue fruitful
10 	 11 	 (NP\NP)/NP 	 1 	 dialogue between
10 	 15 	 (NP\NP)/NP 	 1 	 dialogue than
12 	 11 	 (NP\NP)/NP 	 2 	 management between
14 	 11 	 (NP\NP)/NP 	 2 	 shareholders between
18 	 15 	 (NP\NP)/NP 	 2 	 debate than
18 	 16 	 NP[nb]/N 	 1 	 debate the
18 	 17 	 N/N 	 1 	 debate abstract
18 	 19 	 (NP\NP)/NP 	 1 	 debate about
21 	 19 	 (NP\NP)/NP 	 2 	 pills about
21 	 20 	 N/N 	 1 	 pills poison
<\s>
<s id="wsj_0275.28"> 15
1 	 0 	 N/N 	 1 	 Pozen Mr.
1 	 2 	 (S[dcl]\NP)/NP 	 1 	 Pozen is
5 	 2 	 (S[dcl]\NP)/NP 	 2 	 counsel is
5 	 3 	 NP[nb]/N 	 1 	 counsel the
5 	 4 	 N/N 	 1 	 counsel general
5 	 10 	 (NP\NP)/NP 	 1 	 counsel of
9 	 2 	 (S[dcl]\NP)/NP 	 2 	 director is
9 	 7 	 NP[nb]/N 	 1 	 director a
9 	 8 	 N/N 	 1 	 director managing
9 	 10 	 (NP\NP)/NP 	 1 	 director of
12 	 10 	 (NP\NP)/NP 	 2 	 Investments of
12 	 11 	 N/N 	 1 	 Investments Fidelity
12 	 13 	 (NP\NP)/NP 	 1 	 Investments in
14 	 13 	 (NP\NP)/NP 	 2 	 Boston in
<\s>
